Ureteral Stone
15
3
4
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
6.7%
1 terminated out of 15 trials
87.5%
+1.0% vs benchmark
27%
4 trials in Phase 3/4
43%
3 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Ureteroscopy With High-powered Holmium:Yag Laser Lithotripsy With and Moses On or Moses Off
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
Access Sheath and Stent Trial
Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES)
Temperature Profiles During Laser Activation in Ureteroscopic Lithotripsy
UPURS Trial for Patient-centered Management of Symptomatic Obstructing Stones
Thulium Fiber Laser vs. Holmium:YAG Laser for the Ureteroscopic Treatment of Patients With Urinary Stone Disease
THE EFFECTS OF MIRABEGRON AND TAMSULOSIN FOR PATIENTS WITH URETERAL STENTS
The Performance of the SOLTIVE Laser System for Laser Lithotripsy in Kidney or Ureteral Stones
Impact of Low Dose Fluoroscopy in Ureteroscopy
Effectiveness of Holmium and Thulium Lasers With Ureteroscopy for Urinary Lithiasis
Influence of Patient Decision-Making Aids for Patients With Unilateral Ureteral Stone: A Randomized-Controlled Trial
Silodosin Versus Tamsulosin for Treatment of Ureteral Stones
Phosphodiesterase 5 Inhibitors (PDE5i) (Sildenafil) as Medical Expulsive Therapy in Distal Ureteral Stones
Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones